Bliss GVS Pharma Appoints Two Independent Directors

Bliss GVS Pharma Limited seeks shareholder approval via postal ballot for appointing Vijayanarayanan Mahadevan and Deepak Rameshchandra Shah as Non-Executive Independent Directors for five-year terms.
The remote e-voting period runs from April 10, 2026, to May 09, 2026, with results to be declared on or before May 12, 2026.
The company appointed Vijay Yadav of AVS & Associates as scrutinizer and is using CDSL's e-voting platform for the shareholder approval process.
Both proposed directors are Chartered Accountants with extensive industry experience and have provided declarations confirming their independence and eligibility.